Invivyd at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Invivyd brings 1 presentation to IDWeek 2026 in Washington, and exhibits at Booth 1743. Its program centres on extending its antibody work beyond COVID to measles. It presents an investigational long-acting antibody designed to work across measles variants.

OrganizationIDWeek 2026 Attendance
Invivyd
New Haven, CT
invivyd.com
Biotech
Develops antibodies meant to give stronger protection against viral diseases than natural immunity does, starting with COVID-19.
Booth
Exhibiting at Booth 1743
Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm
Poster
Sat Oct 24
12:15pm–1:30pm
VMS063: A Novel, Highly Potent, Half-life Extended, Pan-measles Variant Investigational Antibody
Poster Hall B-C · Poster P-2082
V3. Studies of treatment and prevention of viral infections

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Invivyd

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction